ATE148341T1 - Benzopyranphenolderivate zur verwendung als immunstimulierende mittel - Google Patents

Benzopyranphenolderivate zur verwendung als immunstimulierende mittel

Info

Publication number
ATE148341T1
ATE148341T1 AT92905459T AT92905459T ATE148341T1 AT E148341 T1 ATE148341 T1 AT E148341T1 AT 92905459 T AT92905459 T AT 92905459T AT 92905459 T AT92905459 T AT 92905459T AT E148341 T1 ATE148341 T1 AT E148341T1
Authority
AT
Austria
Prior art keywords
immunstimulant
benzopyranphenol
derivatives
agents
chem
Prior art date
Application number
AT92905459T
Other languages
English (en)
Inventor
Maria Marconius
Original Assignee
Fockerman Jasmine
Fockerman Michel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fockerman Jasmine, Fockerman Michel filed Critical Fockerman Jasmine
Application granted granted Critical
Publication of ATE148341T1 publication Critical patent/ATE148341T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92905459T 1991-02-15 1992-02-14 Benzopyranphenolderivate zur verwendung als immunstimulierende mittel ATE148341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65680191A 1991-02-15 1991-02-15
US07/809,420 US5449794A (en) 1991-02-15 1991-12-17 Benzopyran phenol derivatives for use as antibacterial agents

Publications (1)

Publication Number Publication Date
ATE148341T1 true ATE148341T1 (de) 1997-02-15

Family

ID=27097268

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95116380T ATE211651T1 (de) 1991-02-15 1992-02-14 Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel
AT92905459T ATE148341T1 (de) 1991-02-15 1992-02-14 Benzopyranphenolderivate zur verwendung als immunstimulierende mittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95116380T ATE211651T1 (de) 1991-02-15 1992-02-14 Benzopyranphenolderivate zur anwendung als bakterienhemmende, antivirale und wundheilende mittel

Country Status (11)

Country Link
US (1) US5449794A (de)
EP (2) EP0707851B1 (de)
JP (1) JP3682721B2 (de)
AT (2) ATE211651T1 (de)
AU (1) AU668348B2 (de)
CA (1) CA2104114C (de)
DE (2) DE69217206T2 (de)
DK (2) DK0707851T3 (de)
ES (2) ES2100335T3 (de)
NZ (1) NZ241633A (de)
WO (1) WO1992014458A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861430A (en) * 1991-12-17 1999-01-19 Jasmine Fockerman Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
DE19740879A1 (de) * 1997-09-17 1999-04-01 Beiersdorf Ag Desodorierende Zubereitungen auf der Basis von Flavonderivaten und/oder Flavanonderivaten, insbesondere von Flavonoiden
AU2904899A (en) * 1998-03-16 1999-10-11 Procter & Gamble Company, The Compositions for regulating skin appearance
DE19813802A1 (de) * 1998-03-27 1999-11-11 Retro Tech Gmbh Anti-virale Wirkung von Propolis durch Inhibition viraler Nukleinsäure Polymerasen
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6555523B1 (en) 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
BR0006272A (pt) * 2000-12-22 2002-08-13 Maria Cristina Marcucc Ribeiro Processo de identificação de tipagens da própolis brasileira
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
RU2185181C1 (ru) * 2001-03-05 2002-07-20 ООО "Тенториум" Способ получения водного экстракта прополиса эй-пи-ви
HU225388B1 (en) * 2001-05-31 2006-11-28 Viola Dr Szabo Rubber device for preventing infections and reducing spread of infections
US6803056B2 (en) * 2001-09-14 2004-10-12 Terence M. Dolak Method and composition for treating viral outbreaks
DE20306600U1 (de) * 2003-04-29 2003-09-04 Karpfl, Peter, 47546 Kalkar Hautpflegeprodukt bzw. Wundpflegemittel
EP2862600B1 (de) * 2011-12-20 2020-02-12 Oriflame Research and Development Ltd. Verbindungen mit Anti-Aging-Wirkung
WO2017075715A1 (en) * 2015-11-05 2017-05-11 Universite Laval Compositions favoring wound repair
EP4031128A4 (de) * 2019-09-16 2023-12-13 Koda Therapeutics, LLC Antimikrobielle verbindungen und zusammensetzungen sowie verwendungen davon

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1057349B (de) * 1955-12-31 1959-05-14 Emi Ltd Schallplatte mit herausnehmbarem und wiedereinsetzbarem Mittelteil und Verfahren zu ihrer Herstellung
AT320869B (de) * 1972-12-08 1975-03-10 Trommsdorff Fa H Verfahren zur Herstellung eines neuen Flavanonderivates
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4238483A (en) * 1979-07-19 1980-12-09 Frazier Stephen E Antimicrobial compositions of matter and a process for preparing antimicrobial compositions of matter from naturally occurring flavanoid glycosides
US4297348A (en) * 1980-04-11 1981-10-27 Rush-Hampton Industries, Inc. Composition and method for the treatment of acne
HU194855B (en) * 1983-02-16 1988-03-28 Alkaloida Vegyeszeti Gyar Process for producing chromene derivatives, insecticide and nematocide compositions containing chromene derivatives as active components
GB8321943D0 (en) * 1983-08-15 1983-09-14 Erba Farmitalia Preparation of 2,3-dihydro-benzopyranone derivatives
WO1988008256A1 (en) * 1987-04-28 1988-11-03 University Patents, Inc. Dihydroflavonol derivatives useful as sweeteners
YU45458B (en) * 1987-10-05 1992-05-28 Vera Rozic Process for obtaining liquid ethanole extract of propolis
US4866080A (en) * 1988-01-13 1989-09-12 Buckman Laboratories International, Inc. Method for the control of mollusks
FR2633182B1 (fr) * 1988-06-23 1993-07-23 Beljanski Mirko Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
GB9201089D0 (en) * 1992-01-18 1992-03-11 Scient Generics Ltd A diagnostic article

Also Published As

Publication number Publication date
ATE211651T1 (de) 2002-01-15
JP3682721B2 (ja) 2005-08-10
AU668348B2 (en) 1996-05-02
DK0707851T3 (da) 2002-04-22
DE69232338D1 (de) 2002-02-14
US5449794A (en) 1995-09-12
AU1277992A (en) 1992-09-15
ES2100335T3 (es) 1997-06-16
DE69217206T2 (de) 1997-08-28
WO1992014458A1 (en) 1992-09-03
CA2104114A1 (en) 1992-08-16
CA2104114C (en) 2004-04-06
DK0571491T3 (da) 1997-08-11
DE69232338T2 (de) 2002-09-19
NZ241633A (en) 1994-06-27
EP0707851A2 (de) 1996-04-24
EP0571491B1 (de) 1997-01-29
EP0707851B1 (de) 2002-01-09
EP0707851A3 (de) 1998-04-01
JPH06508103A (ja) 1994-09-14
ES2171174T3 (es) 2002-09-01
DE69217206D1 (de) 1997-03-13
EP0571491A1 (de) 1993-12-01

Similar Documents

Publication Publication Date Title
ATE148341T1 (de) Benzopyranphenolderivate zur verwendung als immunstimulierende mittel
DE3851769D1 (de) Substituierte Benzazepine, ihre Herstellung und sie enthaltende Arzneimittel.
JPS57146777A (en) Manufacture of 2-penem compounds, novel compounds manufactured thereby and pharmaceutic compositions containing them
GR3000148T3 (en) Benzoûb¨thiophene and benzoûb¨furancarboxamide derivatives, processes for their preparation and therapeutical agents containing them
DE3777544D1 (de) Glutaminsaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische formulierungen.
PL315141A1 (en) Derivatives of aryloacetic acid, method of obtaining them and fungicides containing such derivatives
DE3678797D1 (de) Neue 3-oxadiazol- und 3-carbonsaeure-beta-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
PT80817A (en) Process for the preparation of carbamates,thiocarbamates and dithiocarbamates and their substituted derivatives containing aromatic radicals
ES8203906A1 (es) Procedimiento para la obtencion de cefalosporinas
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
ATE10838T1 (de) 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ATE54448T1 (de) Cyclohexenonderivate, verfahren zur ihrer herstellung und ihre verwendung als herbizide mittel.
US4795832A (en) Salicylic acid amides, their use, and a process for their production
ATE100077T1 (de) 2-hydroxy-3-phenoxypropylaminoverbindungen.
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
DE69709252D1 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
ATE48594T1 (de) Verfahren zur herstellung von acylurethanen und deren verwendung.
DE3882623D1 (de) Phosphorsaeurediester und salze davon.
DE69607890D1 (de) Aromatische Hydroxamsäure-Verbindungen, ihre Herstellung und Verwendung
DE69210639D1 (de) 3-(3,3,3-Trifluor-2-Chlorpropenyl)-2,2-Dimethylcyclopropancarbonsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung als Pestitzide
ATE157959T1 (de) Indanderivate
ATE163639T1 (de) P-hydroxyanilinderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen oder schädlingen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee